Therefore, these results convincingly demonstrate that knockout of Nrf1α causes a significant increase in the tumour size of human carcinoma xenografts resulting from Nrf1α−/− HEA157 cells, when compared with the equivalent xenografts derived from the Nrf1+/+ HepG2 control cells. Here, NRF1 is linked to carcinoma.